Source comparison
Peptides Help with Injury Recovery: Comparison
BPC-157 Upregulates VEGF, promotes angiogenesis and fibroblast activity Tendon, ligament, muscle (soft tissue) Strong preclinical; limited human RCTs 4–8 weeks at injury site Best-supported option for soft tissue repair. Dosing and timing are critical TB-500 (
This comparison does not assign a generated winner or score.
- BPC-157
- Upregulates VEGF, promotes angiogenesis and fibroblast activity
- Tendon, ligament, muscle (soft tissue)
- Strong preclinical; limited human RCTs
- 4–8 weeks at injury site
- Best-supported option for soft tissue repair. Dosing and timing are critical
- TB-500 (Thymosin Beta-4)
- Promotes cell migration and actin binding for structural repair
- Muscle strains, systemic inflammation
- Moderate preclinical; emerging human data
- 4–6 weeks systemic or localized
- Effective for systemic recovery. Less tissue-specific than BPC-157
- GHK-Cu (Copper Peptide)
- Stimulates collagen and glycosaminoglycan synthesis
- Skin wounds, minor soft tissue
- Moderate preclinical for skin; weak for deep tissue
- 2–4 weeks topical or injection
- Proven for dermal repair. Questionable for deep structural injuries
- Ipamorelin + CJC-1295
- Growth hormone secretagogue. Indirect tissue support
- General recovery, muscle preservation
- Weak for acute injury; moderate for chronic recovery
- 8–12 weeks continuous
- Supports baseline anabolic environment. Not injury-specific